FBRX
Forte Biosciences Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$26.74
-0.38 ▼ -1.40%
🌙 3월 13일 5:38 PM ET (한국 3/14 06:38)
$26.92
+0.18 ▲ +0.67%
| Index | - | P/E | - | EPS (ttm) | -4.44 | Insider Own | 13.08% | Shs Outstand | 0.01B | Perf Week | -7.02% |
| Market Cap | 0.33B | Forward P/E | - | EPS next Y | 14.97% | Insider Trans | 0.59% | Shs Float | 0.01B | Perf Month | -10.42% |
| Enterprise Value | 0.24B | PEG | - | EPS next Q | -1.18 | Inst Own | 89.92% | Short Float | 6.54% | Perf Quarter | 32.05% |
| Income | -0.05B | P/S | - | EPS this Y | 64.54% | Inst Trans | 5.37% | Short Ratio | 3.27 | Perf Half Y | 155.64% |
| Sales | 0.00B | P/B | 3.98 | EPS next 5Y | 29.76% | ROA | -89.96% | Short Interest | 0.71M | Perf YTD | -1.94% |
| Book/sh | 6.71 | P/C | 3.59 | EPS past 3/5Y | 32.09% 24.08% | ROE | -110.72% | 52W High | -24.93% ($35.62) | Perf Year | 345.67% |
| Cash/sh | 7.46 | P/FCF | - | Sales past 3/5Y | - | ROIC | -61.53% | 52W Low | 445.71% ($4.90) | Perf 3Y | 8.22% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 77.08% | Gross Margin | - | Volatility(W/M) | 7.74% 8.64% | Perf 5Y | -96.39% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 2.58 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 7.34 | EPS Q/Q | 78.12% | Profit Margin | - | RSI (14) | 40.4 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 7.34 | Sales Q/Q | - | SMA20 | -8.47% ($29.21) | Beta | 3.21 | Target Price | $63.75 |
| Payout | - | Debt/Eq | 0 | Earnings | 11000000 | SMA50 | -9.38% ($29.51) | Rel Volume | 0.58 | Prev Close | $27.12 |
| Employees | 14 | LT Debt/Eq | 0 | EPS/Sales Surpr. | 7.26% - | SMA200 | 49.7% ($17.86) | Avg Volume(3M) | 0.22M | Price | $26.74 |
| IPO | 2017/4/13 | Option/Short | Yes/Yes | Trades | 2434 | Volume | 127,027 | Change | -1.4% |
뉴스 로딩 중...